ACTB source and annotation audit

2026-09-26 — baseline and access record (audit in progress)

Human ACTB is cytoplasmic beta-actin, UniProt P60709, HGNC:132 and NCBI Gene 60. Identity and aliases were checked against NCBI GTR and the HGNC-linked NCBI/PubChem gene record. Current-main baseline was 0efff18e63a816029f64fa64bea40bef0c68c320; all seven top-level ACTB files matched GitHub's authoritative content blobs. Review blob: fddca5a52a4d801096af110aabd4afc87df1d5c5. Open-PR text searches for ACTB and its BRWS1/PS1TP5BP1 aliases returned no overlap. This is a bounded text-search check, not a claim to have inspected every open PR's file list.

The prior COMPLETE document contains 247 seeded annotation rows and one earlier NEW proposal, 171 reference entries, 117 listed PMIDs, and four core-function entries. All 117 listed publications were already cached; the normal parallel fetch-gene-pmids run completed 117/117. A wider citation scan also finds PMID:29581253 and PMID:18765789 (both cached but absent from the reference list), and PMID:29925947 (missing cache). A normal ai-gene-review fetch-pmid 29925947 attempt failed DNS. This legitimate existing citation must not be silently deleted to bypass the publication requirement; absent a successful supported fetch, publication remains draft.

A genuine default Falcon launch with a 1200-second timeout and Perplexity-lite fallback was attempted using supported per-process UV tool/cache directories. Both launches failed dependency resolution at pypi.org before research began. Output was directed to an isolated /tmp/ACTB-research-2026-09-26/ACTB/ directory so the three existing genuine provider reports could not be overwritten. The launch exited unsuccessfully and produced no report. Existing Falcon, Cyberian and Perplexity-lite files remain immutable background sources, not substitutes for primary evidence.

No direct P60709/ACTB entry was found in the current gocams/index.tsv. This is not evidence that actin lacks a process. All 247 source records, including original evidence/reference fields, will be preserved. The earlier broad ATP-dependent-activity NEW proposal requires reassessment because it duplicates existing ATP hydrolysis coverage.

Primary-source recovery and issues under adjudication

The remaining annotation/source groups are still under review; this journal is not a final sign-off.

Completed source adjudication

All 247 seeded annotations have been reviewed; source terms, evidence codes, original references and any source flags remain identical to the baseline. The prior extra NEW GO:0140657 ATP-dependent activity proposal was withdrawn: it merely mirrored the former core and added no useful coverage beyond the existing ATP-hydrolysis assertion. No NEW annotation was introduced. Final actions are 108 ACCEPT, 63 KEEP_AS_NON_CORE, 5 MODIFY, 48 REMOVE and 23 UNDECIDED. The five refinements concern hydrolase→ATP hydrolysis, CaMKII→protein kinase binding, NOS3→nitric-oxide synthase binding, MAL→transcription coregulator binding and myosin binding. Duplicate specific terms supported by distinct original sources are retained.

The three core functions are filament-based structural work, intrinsic ATP hydrolysis, and a contribution to SWI/SNF chromatin remodeling. The last uses contributes_to_molecular_function: GO:0140658, with SWI/SNF as in_complex; it does not assign the SMARCA2/SMARCA4 motor active site to ACTB. NuA4, dynactin and gamma-TuRC memberships remain reviewed separately. The former gamma-TuRC core used generic protein binding and an unverified quotation, so it was not retained as a separate molecular activity.

Primary evidence and source distinctions

Nuclear source consultation

The independent annotation-reviewer consultant read rows 77–120 and the relevant complex sources. The owner separately read the cached abstracts/bodies and incorporated the following bounded conclusions:

Ontology and propagation checks

The following definitions were checked live in GO/GO-consortium resources:

PAINT source blocks contain only the verified ancestral PTN nodes, with source-specific comments. Target self-evidence among descendants is legitimate, not circular. The dynactin ISO donor is ComplexPortal:CPX-26390 for both complex membership and microtubule-based process. Replacing the latter with gamma-TuRC nucleation would change source mechanisms. Direct ComplexPortal API access failed during this session; the stored donor identity and independent UniProt dynactin description were retained without inventing donor species or subunit accessions.

Validation and publication state

The first full just validate human ACTB run passed schema, source/GOA, reference and quote checks, with four nonblocking warnings: source-specific action differences for three duplicated terms and preservation of genuine provider reports without treating them as primary quotes. The final run additionally checks authored ontology terms and the two explicitly listed missing caches. Source-field equality, parsed-YAML equality after stripping trailing spaces, history validation and rendering are recorded in the final manifest. Keep publication draft until normal machine caches for PMID:29925947 and PMID:9845365 are available and final reference validation passes. No cache or generated provider report was hand-written or edited.

Final checks: just validate human ACTB, ai-gene-review validate ... --terms, just validate-history and just render human ACTB exited successfully. Validation retains five warnings, including both missing references. Independent coordinator inspection of all 247 reasons and all three core functions found no biological blocker. The publication remains draft for the two cache requirements.

PR #3184 follow-up: source-bearing support and explicit draft status

This follow-up starts from published head 0f6201a1371e284dc9db890b2a81d3219909801b. The three gene artifact hashes and the earlier history record matched the published manifest before editing. The previous session's decisions and validation totals above describe that earlier state. This section records the revised state; the published history record is untouched.

The generic GO:0005515 row from PMID:17502619 is now REMOVE. The same source and IPI code already supply the retained GO:0050998 nitric-oxide synthase binding annotation, so proposing that term again added no coverage. Actual cached results replace the title: human platelet G-actin binds NOS3, and the G-actin/NOS3/Hsp90 complex increases NOS activity. The specific NOS-binding and NOS-regulator rows remain non-core, and removing the generic annotation does not deny the interaction.

The actual file contains 12 GO:0042802 rows, all IPI, rather than the 18 stated in the review. The live GO definition describes binding to an identical protein and includes protein homopolymerization as a related synonym. These annotations remain ACCEPT because direct human beta-actin filament assembly establishes the biological function. Their reasons now distinguish that positive target evidence from the unresolved provenance of each original interaction assay; none claims that an original paper title establishes an ACTB–ACTB interaction.

The independent target evidence is PMID:25255767, original publisher full text. Results, Actin assembly and disassembly, and Figure 4A measure polymerization of recombinant wild-type human beta-actin alongside p.R183W and p.E364K. Wild type has a polymerization half-time of 20.6 ± 2.4 min; the mutant preparations polymerize more slowly. Figure 1 and the preceding production section confirm the human recombinant protein with an antibody that does not recognize insect actin. Preparations nevertheless contain 5–15% endogenous Sf9 actin, so the experiment does not establish an absolutely isoform-pure homopolymer. The observed wild-type filament assembly supports self-association. This is independent biological corroboration, not a claim to have recovered all twelve original ACTB pair records. The primary result excerpt is attached to the filament core; the individual rows cite this source and quote actual study context from their original papers. The local cache remains abstract-only, and the external full-text route is recorded separately.

Source-specific boundaries for the twelve rows are explicit. PMID:17404223 demonstrates CaMKII bundling of F-actin; PMID:18234857 reconstructs F-actin alone and with fimbrin; PMID:20383143 examines alpha-actinin domains on the filament. These establish filament or partner context without independently identifying the actin reagent as human ACTB in the available material. PMID:19000816's accessible abstract describes parasite profilin; the exact actin reagent and homotypic assay remain unresolved, and no wrong-gene claim is made. For the eight human interaction-screen sources (PMID:16189514, PMID:21516116, PMID:25416956, PMID:25502805, PMID:25910212, PMID:29892012, PMID:31515488, PMID:32296183), the individual ACTB–ACTB supplemental record and, where relevant, allele were not independently recovered. The original IPI fields remain unchanged. Retention follows the guideline permitting curator deference when the target function is independently established.

The title-support audit also covered the other retained and modified annotations named in the review. Seventy-eight rows had title-only support replaced by actual cached assay, result or source-scope passages. This includes the rat CA1 beta-actin photoactivation study (PMID:18341992), neuronal BAF transcription (PMID:17920018), source-specific chromatin remodeling experiments, nuclear actin/NDHII (PMID:11687588), NOS3, NET, DYRK1A, PDI, membrane/vesicle fractions and focal adhesions. The myosin-binding modification now uses the actual external Figure 6 result from PMID:25255767 instead of a title and a section heading. Complex-level results are distinguished from ACTB-specific perturbations, and the ACTB–ACTL6 structural linkage is cited from the existing cached Reactome source where it supplies that bridge. The PC3 proliferation inference explicitly identifies GLTSCR1/GLTSCR1L as the perturbed subunits; their necessity is not presented as an ACTB knockout result.

The full original PMID:12368262 Results and Figure 3A were recovered again by indexed primary search ("PMC187451" "Western" "β"). They directly report beta-actin in affinity-purified mouse-brain and HeLa complexes. That result now accompanies the bBAF membership assessment with the species and preparation limits preserved. External full-text recovery does not change the incomplete local-cache flag.

The gamma-TuRC microtubule-nucleation NAS row is UNDECIDED. GO:0007020 concerns the initial aggregation of alpha/beta-tubulin heterodimers into a seed, under microtubule polymerization. PMID:39321809's primary abstract establishes luminal actin in non-activated gamma-TuRC and release during CM1-dependent activation. This establishes the complex association; it does not alone resolve which nucleation step ACTB structurally performs. Release during activation also does not prove a universal absence from active complexes. Direct Cell, DOI and ScienceDirect opens did not yield the full original Results during this follow-up, so neither a confident process acceptance nor rejection is warranted. No new assembly or regulation process is proposed.

Dynactin, gamma-TuRC and the three NuA4 membership rows are retained as KEEP_AS_NON_CORE, reflecting specialized structural pools outside the synthesized filament and SWI/SNF cores. Their physical membership is not rejected. The PAINT and ISO propagation blocks retain the verified node/donor and use NO_FAILURE_NON_CORE. BAF/PBAF/BRM/neural/GBAF membership remains ACCEPT: these are compositionally qualified forms of the existing SWI/SNF structural contribution, rather than separate motor activities. Three expert questions now record the wrong PMID's intended source, ACTB's activation-state-dependent gamma-TuRC role, and unresolved original self-interaction assay records.

Both required cache fetches were retried once using the normal machine fetcher and existing offline runtime: PMID:9845365 and PMID:29925947 each returned Cached 0/1 with a DNS resolution error. No cache was manufactured or edited. Their verified primary evidence and citations are preserved, including the nuclear core's PMID:9845365 support. Merely moving its quote would not remove the repository's citation-cache requirement. The YAML status is now DRAFT, consistent with these two open cache gates. No provider report, source GOA, UniProt record, source annotation field or original reference identity changed.

Final action totals for this follow-up are 103 ACCEPT, 67 KEEP_AS_NON_CORE, 4 MODIFY, 49 REMOVE and 24 UNDECIDED across the same 247 seeded annotations, with 175 references, three cores and no NEW annotation. All removals remain generic protein-binding annotations. Final validation, rendering, source-preservation evidence and exact file hashes are recorded in the follow-up manifest.

Prepublication metadata and supporting-excerpt check

The eleven references PMID:11078522, PMID:14966270, PMID:15121898, PMID:17404223, PMID:19199708, PMID:22664934, PMID:23382103, PMID:23533145, PMID:24327345, PMID:27153538, PMID:30280653 retain full_text_unavailable: false because their cache metadata records available full text. Missing extracted sections or supplementary identification tables remain described in each reference review; partial extraction is not the same as no full-text access.

Reopened the primary Wiley page for PMID:25255767 (https://febs.onlinelibrary.wiley.com/doi/10.1111/febs.13068): the publisher labels it Free Access, with Results and Figure 4A accessible. No Creative Commons or comparable redistribution license was established from that page. Its concise wild-type polymerization excerpt is now included in all twelve same-protein-binding supporting entries as well as the core, using supporting_text_fulltext for publisher text not licensed for wholesale repository redistribution. The original machine cache remains abstract-only and unchanged.

2026-09-27 normal publication-cache recovery

The missing PMID:9845365 and PMID:29925947 records are now present as exact
normal-fetch output. The first remains abstract-only and directly describes
beta-actin/BAF53 purification and their contribution to BRG1 activity and
chromatin association. It does not assign the BRG1 motor reaction to ACTB.
The second now contains XML full text from PMC6145447. Results and Methods
separate beta-actin recruitment in Xenopus extracts, human U2OS actin-chromobody
imaging and repair-focus movement, and mouse-tail fibroblast perturbations.
Actin-chromobody imaging is not an ACTB-specific knockout experiment. The source
supports the existing nuclear localization and contextual interpretation; no
new repair-process annotation is proposed. Its full_text_unavailable flag is
false; the first source retains true. The obsolete missing-cache sentence in
the nucleus reason now states the source's nuclear-actin context.

Both records come from normal fetch Actions run 36286975328, head
5946477c8ac79ade0709264c775ea1262b108438, artifact 10920674630, verified ZIP
SHA-256 c0ffe4a66b80278af34b44aab6a3ae354ffd5699236b3a486ca95527be5e9713.
The per-file import receipt is
tmp/verified-reference-records/local-import-receipt.json. This dated entry
supersedes the earlier missing-cache status, without rewriting prior history.
All 247 source assertions and actions, three cores, 175 reference identities
and machine/provider files are preserved. Targeted validation, render, history
and exact byte checks are recorded in the closure manifest. Status COMPLETE
requires zero validation warnings; an unused-provider advisory is independent
of the closed cache gate. No cache content was edited.

2026-09-27 post-merge source12 assessment

The full audit merged through PR #3184 as c7078166039c9abd5c62704489283403eb520007.
The last approved review head was 3635743f96850ac6674e5af2983d4d4b123ee7df.
Fresh main 587fad096c3c8a338b95465f53bf654968f06a8a retained the exact eight
canonical ACTB files; no overlapping open ACTB PR or proposed follow-up branch
was found. This follow-up preserves all 247 annotation source objects and
actions
, all three core biological assertions, the original 175 reference
identities, and every machine/provider file. It adds assessments of nine
normally recovered publications and five genuine provider-linked sources still
awaiting a cache, plus a separately identified DOI-only publisher review. Recovery does not turn a provider's interpretation into an
independent experiment.

The nine records were imported unchanged from source12; the canonical import
receipt is tmp/source12-canonical-import-receipt.json, SHA-256
111b2251162b55efec7612ebc869e75650cf6ac69cb26effda29b6e6c2038cee.
Their exact bytes, hashes and null publication-base paths are included in this
follow-up manifest. Source13 adds no ACTB-owned record. Eight of the nine have
extracted bodies; PMID:11416185 remains abstract-only. Available XML does not
imply that every supplementary method, figure or identification table was read.

Actual source scope

Primary PubMed identities, the recovered source records and relevant actual
Methods/Results were checked separately. The full-record assessments are in
references[].reference_review; exact machine-fetched titles are retained.
No action or core biological change is justified by these nine sources.

External evidence attachments and access

The merged review's optional evidence-format concern was reassessed. Nineteen
supporting_text_fulltext attachments represented external passages absent
from the local extraction, without an established restriction on sharing the
full text. They have been removed from that special field. Each primary PMID
remains attached directly to the claim. A relevant ordinary cached quote is
retained where available; a reference-only attachment is used when the precise
assay passage is external. Notes are not substituted as the supporting source,
and no external passage is presented as a cached quote. In particular:

Recursive provider census and five remaining cache requirements

The census includes all authored YAML/Markdown and all three immutable provider
reports, with HTML/URL decoding, title-only bibliography review and DOI/PMCID
matching against real metadata. The incorrect provider DOI
10.1101/cshperspect.a018218 identifies an unrelated epidermal-barrier paper,
but its adjacent PMC5749151 link identifies the genuine Svitkina review
PMID:29295889, DOI 10.1101/cshperspect.a018267.
Likewise, DOI 10.1016/j.isci.2022.105181 does not identify the claimed
actin-processing study, but PMC9556930 identifies PMID:36248738,
DOI 10.1016/j.isci.2022.105186.
Both primary identities were verified. The latter's accessible summary and
indexed Results concern actin as an aminopeptidase substrate, not an actin
processing enzyme; this follow-up did not comprehensively read all its Methods.

The third incorrect DOI 10.1016/j.tibs.2018.12.008 is excluded as an identifier
mismatch, but the adjacent exact title resolves a real review:
Actin Post-translational Modifications: The Cinderella of Cytoskeletal Control,
PMID:30611609, DOI 10.1016/j.tibs.2018.11.010.
Primary PubMed identifies Varland, Vandekerckhove and Drazic as its authors,
not the generated provider author. Its abstract addresses regulation of actin
through modifications; it does not establish a new ACTB enzyme activity.

The provider's title-only 1954 pair also identifies real indexed sources:
PMID:13165697, DOI 10.1038/173971a0, and
PMID:13165698, DOI 10.1038/173973a0.
PubMed metadata and Nature bibliographic records identify the authors, titles
and pages. Neither PubMed record has an abstract and the full bodies were not
read. Historical muscle context is not recast as a human ACTB-specific assay.
Their citation identities are verified separately from their unassessed
experimental details.

The provider also mislabels the already cached Essential nucleotide- and
protein-dependent functions of Actb/beta-actin
: its correct DOI and PMC6077724
identify PMID:30012594. The adjacent literal PMID:30012616 identifies an
unrelated influenza-hemagglutinin simulation paper. That wrong literal is
retained in the immutable provider but excluded from biological support; no
additional source retrieval is needed for the correctly identified actin paper.

Falcon's title-only Housekeeping gene and its internal control resolves to
the 2025 Adhikari and colleagues review in World Journal of Pharmaceutical
Research
14(21):558-574, DOI 10.5281/zenodo.17474289.
The publisher abstract and indexed
original PDF title page
were checked on 2026-09-27. Its abstract concerns expression-normalization
controls and cautions that their stability depends on experimental context;
it supplies no new ACTB mechanism. No PMID was established, and the full body
was not assessed. This separate DOI-only source record is not replaced by an
invented PubMed identifier or manufactured publication cache.

Three finite normal fetches ended with exit 1 and 0/5 cached, all DNS
failures: two PMC-resolved sources (/tmp/ACTB-pmc-corrections-fetch.log), the
Cinderella review (/tmp/ACTB-cinderella-fetch.log), and the two historical
papers (/tmp/ACTB-historical-pair-fetch.log). Each source was attempted once.
No source was manufactured or overwritten. This follow-up remains DRAFT
with five PMID cache gates: 13165697, 13165698, 29295889, 30611609 and 36248738.
These are additional to the nine recovered source12 records. The DOI-only
publisher record and three incorrect DOI mappings are explicitly separate in
the census. Provider bytes remain unchanged; erroneous bibliographic details
and species attributions are not endorsed. The manifest records the complete
finite census, terminal receipts and exact hashes.

2026-09-27 — Source19 evidence and PR #3302 attachment follow-up

This bounded follow-up preserves all 247 original annotation assertions and
actions, all three core functions, the biological description, raw sources,
provider reports and published history. The five normally recovered source19
records were read from the verified staging archive and then compared with
the coordinator's exact canonical import. The source12 missing-cache statement
above is historical and is superseded by that verified recovery. No new
annotation is proposed from these papers.

Evidence attachments and public primary access

The review correctly identified two off-topic quotations. The general
endothelial-permeability sentence in PMID:30280653 does not establish actin's
contribution to the blood-brain barrier, and the BAF53b assembly sentence in
PMID:12368262 does not identify beta-actin. Both quotes are removed while
their primary reference attachments and annotation judgments are retained.
The exact existing Reactome R-HSA-9933238 quote naming the ACTB–ACTL6A/B module
remains attached to bBAF membership.

The actual local records are partial full-text extractions, not both
abstract-only: PMID:12368262 contains the abstract and Discussion, whereas
PMID:30280653 contains the abstract and Introduction. Neither contains the
target-specific passage at issue. Their retained availability flags report
these actual partial bodies, with the omitted evidence stated explicitly.
No cache was edited and no inference is drawn from the missing sections.

Primary access was rechecked on 2026-09-27:

Public primary evidence remains attributed to the original PMID and primary
URL. The schema's supporting_text_fulltext field is reserved for text that
cannot be publicly shared or committed; cache absence alone does not meet
that condition. These accessible passages are therefore documented here and
in source-specific reasons, without a self-referential notes-file evidence
proxy. The myosin row retains its direct primary reference and explicit
external-access scope.

Count reconciliation: the preceding source12 note and published history
correctly describe removal of nineteen actual full-text fields, leaving
zero. Parsing the exact prior YAML finds seventeen annotation attachments and
two core attachments. The reviewer's text search counts twenty deleted lines
because it also matches a reference-review sentence mentioning the field name;
that sentence is not another field. The published history is preserved, and
this entry records the semantic count without changing any annotation.

Five recovered records: actual access and experimental scope

Source Actual record and bounded assessment
PMID:13165697 Bibliographic-only; no abstract exists in PubMed despite the generated Abstract heading. A. F. Huxley and R. Niedergerke's 1954 Nature identity is verified. The original body, organism and ACTB isoform are not established by this record.
PMID:13165698 Bibliographic-only; no PubMed abstract. H. Huxley and J. Hanson's paired 1954 Nature identity is verified. This remains historical muscle background, without an invented human ACTB experiment.
PMID:29295889 Abstract-only Svitkina review of actin cytoskeleton and motility. The recovered title/DOI/PMCID identify the intended work behind the provider's correct PMC link and incorrect adjacent DOI. No new target-specific assay is claimed.
PMID:30611609 Abstract-only Varland, Vandekerckhove and Drazic review of actin modifications. Actin is the regulated substrate; the review does not assign ACTB the enzymes' reactions. The preserved provider's author/DOI mismatch remains explicitly corrected by the primary identity.
PMID:36248738 Full extracted Results, Discussion, Limitations and STAR Methods read. Mouse embryonic fibroblasts/tissues, human HAP1 cells and commercial human platelet actin are explicitly separated. The provider's adjacent wrong DOI remains unendorsed.

In PMID:36248738, mass spectrometry detects low-abundance N-terminal
beta-actin Asp removal; the gamma-actin processing pattern differs. Human
HAP1 DNPEP/ENPEP knockout affects processing, F-actin and cellular morphology,
but the authors caution that both peptidases have other substrates. Purified
ENPEP cleaves non-acetylated synthetic actin N-terminal peptides; DNPEP has
no detectable activity in that particular peptide assay, and neither enzyme
cleaves the acetylated peptides tested. These assays establish actin as a
substrate, not the entity performing proteolysis. Relative MS intensity is not
absolute quantification, and not every cellular phenotype can be assigned
solely to ACTB processing. No new process or molecular-function assertion is
added. External supplements were not separately read.

The recursive census retains the earlier explicit wrong-provider-identifier
exclusions and the separately identified DOI-only housekeeping-gene review.
All three provider reports remain byte-for-byte unchanged. Recovery of a
bibliographic record closes its cache-presence requirement without pretending
that an unavailable original paper was read.

The canonical import receipt tmp/source19-canonical-import-receipt.json
records exact normal-fetch bytes for all five sources; each was independently
compared with its staged record. The final recursive census finds all 136
required PMID records and 44 Reactome records present
. Twenty-five resolved
DOI mappings, three wrong-provider DOI mappings, the one wrong literal PMID,
and the separately assessed DOI-only review retain their explicit dispositions.
No additional source was fetched or manufactured in this follow-up.

Source preservation and all 254 cached supporting quotations pass independent
checks. The coordinator's complete semantic-delta read found no biological
blocker. Targeted validation passes with the four existing advisories: three
source-specific action differences and the unused-provider-reference advisory.
The YAML remains DRAFT because advisories persist; the five missing-cache
gates are closed and no longer require keeping the PR in draft. The new history
record, rendered page and exact publication manifest are validated separately.